Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Butts C, Socinski MA, Mitchell PL, Thatcher N, Havel L, Krzakowski M, Nawrocki S, Ciuleanu TE, Bosquée L, Trigo JM, Spira A, Tremblay L, Nyman J, Ramlau R, Wickart-Johansson G, Ellis P, Gladkov O, Pereira JR, Eberhardt WE, Helwig C, Schröder A, Shepherd FA; START trial team. Butts C, et al. Lancet Oncol. 2014 Jan;15(1):59-68. doi: 10.1016/S1470-2045(13)70510-2. Epub 2013 Dec 9. Lancet Oncol. 2014. PMID: 24331154 Free article. Clinical Trial.
Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database Analysis.
Mandó P, Fabiano V, Gomez Guasch S, Colucci G, Sánchez-Bayona R, Coló F, Loza M, Von Stecher F, Amat M, de la Vega M, Costanzo MV, Nervo A, Nadal J, Chacón R, Perazzo F; RCM Database Contributors. Mandó P, et al. Among authors: perazzo f. JCO Glob Oncol. 2024 Nov;10:e2400123. doi: 10.1200/GO.24.00123. Epub 2024 Nov 27. JCO Glob Oncol. 2024. PMID: 39602672
In-Depth Analysis of the Peripheral Immune Profile of HER2+ Breast Cancer Patients on Neoadjuvant Treatment with Chemotherapy Plus Trastuzumab Plus Pertuzumab.
Pesce Viglietti AI, Bordignon MB, Ostinelli A, Rizzo MM, Cueto G, Sanchez MB, Perazzo F, Amat M, Coló F, Costanzo MV, Nervo A, Nadal J, Crimi G, Mc Lean I, Spengler EA, Mordoh J, Mandó P, Levy EM. Pesce Viglietti AI, et al. Among authors: perazzo f. Int J Mol Sci. 2024 Aug 27;25(17):9268. doi: 10.3390/ijms25179268. Int J Mol Sci. 2024. PMID: 39273217 Free PMC article.
Effect of receiving a customizable brochure on breast cancer patients' knowledge about their diagnosis and treatment: A randomized clinical trial.
Villarreal-Garza C, Ferrigno AS, De la Garza-Ramos C, Vazquez-Juarez D, Moreno-Jaime B, Remolina-Bonilla Y, Segura-Gonzalez M, Mariscal-Ramirez I, Perazzo F, Garnica-Jaliffe G, Neciosup-Delgado S, Conde-Flores E, Mysler S, Hernandez-Ayala A, Barajas-Sanchez A, Rios Mercado MDS, Noh-Vazquez NM, Garcia-Rodriguez R, Platas A, Tamez-Salazar J, Mireles-Aguilar T, Platas A. Villarreal-Garza C, et al. Among authors: perazzo f. Cancer Med. 2023 Jul;12(14):15612-15627. doi: 10.1002/cam4.6215. Epub 2023 Jun 14. Cancer Med. 2023. PMID: 37317676 Free PMC article. Clinical Trial.
HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks.
Mandó P, Waisberg F, Pasquinelli R, Rivero S, Ostinelli A, Perazzo F. Mandó P, et al. Among authors: perazzo f. Onco Targets Ther. 2023 Feb 19;16:115-132. doi: 10.2147/OTT.S335934. eCollection 2023. Onco Targets Ther. 2023. PMID: 36844609 Free PMC article. Review.
71 results